[ad_1]
Canada's warnings on drugs should be more consistent with those of other countries: UBC study
The professor asks Health Canada to be more transparent by providing easily accessible information
<div clbad = "post-attachment support" alt = "<640">
The chief investigator of a new study said that between 2007 and 2016, Health Canada had issued safety warnings for only 50% of the drug safety issues identified in the United States , Australia and the United Kingdom. (Photo of the Black Press Media folder)
A professor at the University of British Columbia said that Health Canada needed to be more consistent with other countries in warnings about the safety risks of certain drugs, especially if others had already advised patients taking the same drugs.
Barbara Mintzes is the principal investigator of a new study and indicates that between 2007 and 2016, Health Canada issued safety warnings that for 50% of safety issues identified drugs in the United States, Australia and the United Kingdom.
She joined the researchers who badyzed 1,441 reviews during this period and found that the regulators of the four countries were only consistent in the decision to warn their populations 10% of the time of problems related to the same drug .
Associate Professor affiliated with the School of Population and Public Health at the University of British Columbia is also asking Health Canada to be more transparent by providing patients with easily accessible online information about patients. adverse effects of various drugs.
Health Canada did not immediately respond to a request for comment.
The study is published in JAMA Internal Medicine, published by the American Medical Association, and also includes research from York University in Toronto and from the University of Sydney in Australia.
The Canadian press
Like us on Facebook and follow us on Twitter
<! – View comments ->
